Evidence map›Paper›PMID 21664235›Full record

ReviewMolecular and cellular endocrinology2012

The road less traveled: new views of steroid receptor action from the path of dose-response curves.

S Stoney Simons, Carson C Chow

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S Stoney SimonsSteroid Hormones Section, NIDDK/CEB, NIDDK, National Institutes of Health, Bethesda, MD 20892-1772, United States. steroids@helix.nih.gov
Carson C Chow

Funding

Modeling gene transcriptionZIADK075069 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHOW, CARSON · 2012 to 2025
$2.9M
Modeling and data analysis of obesity, insulin resistance, and diabetesZIADK013022 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI CHOW, CARSON · 2009 to 2025
$2.8M
Modulation of parameters of glucocorticoid receptor-mediated gene inductionZIADK057800 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONS, S STONEY · 2009 to 2015
$2.6M
Modulation of parameters of glucocorticoid receptor-mediated gene repressionZIADK047040 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONS, S STONEY · 2009 to 2015
$2.0M
Mechanisms for glucocorticoid vs. progesterone receptor-specific gene regulationZIADK047041 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONS, S STONEY · 2009 to 2014
$1.3M
Mechanism of action of STAMP - a new comodulator of glucocorticoid receptorsZIADK047039 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONS, S S · 2009 to 2013
$984k
Intramural NIH HHS ZIA DK047040Intramural NIH HHS ZIA DK047041Intramural NIH HHS ZIA DK057800
6 · The paper itself

Abstract

Conventional studies of steroid hormone action proceed via quantitation of the maximal activity for gene induction at saturating concentrations of agonist steroid (i.e., A(max)). Less frequently analyzed parameters of receptor-mediated gene expression are EC(50) and PAA. The EC(50) is the concentration of steroid required for half-maximal agonist activity and is readily determined from the dose-response curve. The PAA is the partial agonist activity of an antagonist steroid, expressed as percent of A(max) under the same conditions. Recent results demonstrate that new and otherwise inaccessible mechanistic information is obtained when the EC(50) and/or PAA are examined in addition to the A(max). Specifically, A(max), EC(50), and PAA can be independently regulated, which suggests that novel pathways and factors may preferentially modify the EC(50) and/or PAA with little effect on A(max). Other approaches indicate that the activity of receptor-bound factors can be altered without changing the binding of factors to receptor. Finally, a new theoretical model of steroid hormone action not only permits a mechanistically based definition of factor activity but also allows the positioning of when a factor acts, as opposed to binds, relative to a kinetically defined step. These advances illustrate some of the benefits of expanding the mechanistic studies of steroid hormone action to routinely include EC(50) and PAA.

Indexed as

Data Interpretation, StatisticalDose-Response Relationship, DrugGene ExpressionGene Expression RegulationHumansReceptors, SteroidSteroidsTranscriptional ActivationReceptors, SteroidSteroids

Identifiers

PMID21664235
PMCPMC3184374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.